Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease
The multimodal MRI biomarkers offer a more comprehensive understanding of PSP and PD patients from both morphological and pathological perspectives. By combining these MRI biomarkers, it may have the potential to promote reliable MRI-based identification of PSP and PD patients, and facilitate more accurate clinical diagnosis.
Authors
- Cheng Zhao
- Guangbin Wang (ORCID: https://orcid.org/0000-0001-7410-5540)
- Tao Gong (ORCID: https://orcid.org/0000-0001-9689-0420)
- Aocai Yang (ORCID: https://orcid.org/0000-0003-0563-6959)
- Yuanyuan Xiang (ORCID: https://orcid.org/0000-0002-9218-1886)
- Yiming Liu (ORCID: https://orcid.org/0000-0001-7200-7197)
- Yufan Chen (ORCID: https://orcid.org/0000-0002-3501-9807)
- Yang Zhao (ORCID: https://orcid.org/0000-0002-7229-1324)
- Lingyan Zhou (ORCID: https://orcid.org/0000-0002-3255-9736)
- Weibo Chen (ORCID: https://orcid.org/0000-0002-4727-3642)
- Zhanfang Sun
- Tong Chen (ORCID: https://orcid.org/0009-0006-1083-9100)
Institutions
- Philips (China) (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Neurobiology of Disease
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.nbd.2025.107076
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
- Shandong First Medical University